Basel Medical regains Nasdaq $1 minimum bid price compliance

Basel Medical Group Ltd

BMGL

0.00

Basel Medical Group regained compliance with Nasdaq’s $1 minimum bid price requirement, removing the risk of delisting tied to the rule.
Nasdaq had flagged the stock on Jan. 22, 2026 for trading below $1 for 30 consecutive business days.
The shares closed at $1 or higher for 10 straight sessions from June 23, 2026 to July 7, 2026, meeting Listing Rule 5550(a)(2).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607100630PRIMZONEFULLFEED9760280) on July 10, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.